Vitamin K status in patients with Crohn's disease and relationship to bone turnover

American Journal of Gastroenterology

Volumn 99, Issue 11, 2004, Pages 2178-2185

  Duggan, Paula ^b   O'Brien, Maria ^b   Kiely, Mairead ^b   McCarthy, Jane ^b   Shanahan, Fergus ^b   Cashman, Kevin D ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; ANTIBIOTIC AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; COLLAGEN TYPE 1; CORTICOSTEROID; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN; PREDNISOLONE; VITAMIN D; VITAMIN K GROUP; WARFARIN;

ADULT; ARTICLE; BONE TURNOVER; CALCIUM INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FOOD INTAKE; HUMAN; MALE; OSTEOLYSIS; OSTEOPENIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; VITAMIN BLOOD LEVEL; VITAMIN K DEFICIENCY;

ADULT; BONE DISEASES, METABOLIC; BONE REMODELING; CALCIUM, DIETARY; COLLAGEN; COLLAGEN TYPE I; CREATININE; CROHN DISEASE; FEMALE; HUMANS; MALE; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDES; VITAMIN D; VITAMIN K 1;

EID: 8844279126     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40071.x     Document Type: Article

References (43)

1. Bjarnason I, Macpherson A, Mackintosh C, et al. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-33.
2. Szulc P, Meunier PJ. Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease? Lancet 2001;357:1995-6.
3. Dresner-Pollak R, Karmeli F, Eliakim R, et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998;93:1483-90.
4. Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study. Aliment Pharmacol Ther 1996;10:777-86.
5. Silvennoinen J, Lamberg-Allardt C, Karkkainen M, et al. Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med 1996;240:285-92.
6. Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 2000;46:S1-S8.
7. Arnaud SB, Goldsmith RS, Lambert PW, et al. 25-Hydroxyvitamin D3: Evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med 1975;149:570-72.
8. Compston JE, Creamer B. Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut 1977;18:171-5.
9. Haderslev KV, Jeppesen PB, Sorensen HA, et al. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut 2003;52:653-8.
10. Geerling BJ, Badart-Smook A, Stockbrugger RW, et al. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000;54:514-21.
11. Krasinski SD, Russell RM, Furie BC, et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr 1985;41:639-43.
12. Weber P. Vitamin K and bone health. Nutrition 2001;17:880-8.
13. Schoon EJ, Müller MCA, Vermeer C, et al. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: Another pathogenetic factor of osteoporosis in Crohn's disease? Gut 2001;48:473-7.
14. Sokoll LJ, Sadowski JA. Comparison of biochemical indexes for assessing vitamin K status in a healthy adult population. Am J Clin Nutr 1996;63:566-73.
15. Szulc P, Chapuy MC, Meunier PJ, et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91:1769-74.
16. Cashman KD, Ginty F. Bone. In: Caballero B, Trugo L, Finglas P, eds. Encyclopedia of food sciences and nutrition. London: Academic Press, 2003:557-65.
17. Booth SL, Lichtenstein AH, O'Brien-Morse M, et al. Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr 2001;74:783-90.
18. Dresner-Pollak R, Karmeli F, Eliakim R, et al. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 2000;95:699-704.
19. Collins A, O'Brien MM, Flynn A, et al. Comparison of a 69-item food frequency questionnaire (FFQ) with a 14-day dietary (DH) to estimate vitamin D intakes in 50-75-year-old Irish women. Proc Nutr Soc 2003;62:21A.
20. 1) intakes and food sources in 18-64 year old Irish adults. Br J Nutr 2004;92:151-8.
21. Ministry of Agriculture, Fisheries and Food. A photographic atlas of food portion sizes. London: Ministry of Agriculture, Fisheries and Food, 1997.
22. Food Standards Agency. Food Portion Sizes, 3rd ed. London (TSO), 2002.
23. 1) content of foods. Br J Nutr 2000;83:389-99.
24. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56.
25. Rosen HN, Dresner-Pollak R, Moses AC, et al. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 1994;54:26-9.
26. Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999;45:1359-68.
27. Silvennoinen JA, Risteli L, Karttunen TJ, et al. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 1996;38:223-8.
28. Bischoff SC, Herrmann A, Goke M, et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997;92:1157-63.
29. Robinson RJ, Iqbal SJ, Abrams K, et al. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998;12:699-705.
30. Schoon EJ, Geerling BG, Van Dooren IM, et al. Abnormal bone turnover in long-standing Crohn's disease in remission. Aliment Pharmacol Ther 2001;15:783-92.
31. Miheller P, Toth M, Molnar E, et al. Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases. Orv Hetil 2001;142:1557-60.
32. Martin A, Fries W, Luisetto G, et al. Bone density and calcium metabolism in patients with long-standing quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1994;6:611-6.
33. Silvennoinen JA, Karttunen TJ, Niemelä SE, et al. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995;37:71-6.
34. Scientific Committee for Food. Reports of the Scientific Committee for Food series no. 31. Nutrient and energy intakes for the European Community. Luxembourg: Commission of European Communities, 1993.
35. Cashman KD, Shanahan F. Is nutrition an aetiological factor for inflammatory bowel disease? Eur J Gastroenterol Hepatol 2003;15:607-13.
36. Riggs BL, Melton LJ III, O'Fallon WM. Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 1996;18:S197-S201.
37. Hansen MA, Overgaard K, Riis B, et al. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. Br Med J 1991;303:961-4.
38. Parfitt AM. Age-related structural changes intrabecular and cortical bone: Cellular mechanisms and biomechanical consequences. Calcif Tissue Int 1984;36:S123-S128.
39. Hill TR, O'Brien MM, Kiely M, et al. Serum 25-OH-D and PTH concentrations in a group of 50-70 year old women. Proc Nutr Soc 2002;61:71A.
40. Hill TR, O'Brien MM, Kiely M, et al. Seasonal variation in vitamin D status in a group of 50- to 70-year-old Irish women. Proc Nutr Soc 2003;62:22A.
41. Hara K, Akiyama Y, Ohkawa I, et al. Effects of menatetrenone on prednisolone-induced bone loss in rats. Bone 1993;14:813-8.
42. Sato Y, Tsuru T, Oizumi K, et al. Vitamin K deficiency and osteopenia in disuse-affected limbs of vitamin D-deficient elderly stroke patients. Am J Phys Med Rehabil 1999;78:317-22.
43. 1 supplementation on vitamin K status in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 1997;24:512-7.